HELLP syndrome - Therapeutic dilemma

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) is a severe and life-threatening form of preeclampsia. The classical symptoms, despite the typical laboratory evaluation, are epigastric or right upper quadrant pain, nausea and vomiting; the classical signs of preeclampsia may be absent in 20% of women. As no reliable clinical and laboratory indicators exist, as well as no precisely defined cut-off values in predicting the course and prognosis, the outcome of HELLP syndrome is unpredictable. The high maternal morbidity and mortality are mainly due to the development of disseminated intravascular coagulation (DIC); the frequency of DIC has been shown to increase significantly with the time interval between diagnosis and delivery. The management of HELLP syndrome has been controversial, with some authors recommending a conservative approach to induce fetal maturity in pregnancies below the 32(nd) (34(th)) week of gestation, whereas the majority recommend immediate delivery by Cesarean section in patients with an unfavorable cervix irrespective of the gestational age. It is generally agreed that early diagnosis by laboratory screening methods is mandatory and that patients with the HELLP syndrome should be transferred to a perinatal center. A literature review since 1990 clearly demonstrates that aggressive management is associated with a significant reduction in maternal and perinatal mortality. Conservative management is only justified in cases of fetal immaturity under of following conditions: a) no evidence of progression of the disease, b) no suspected or manifest DIC, c) fetal well-being, and d) intensive monitoring of the patient in cooperation with experienced anesthesiologists and neonatologists.

Original languageEnglish
Pages (from-to)32-36
Number of pages5
JournalArchives of Gastroenterohepatology
Volume17
Issue number1
Publication statusPublished - Jan 1 1998

Fingerprint

HELLP Syndrome
Disseminated Intravascular Coagulation
Maternal Mortality
Pre-Eclampsia
Pregnancy
Perinatal Mortality
Therapeutics
Patient Compliance
Hemolysis
Cervix Uteri
Cesarean Section
Nausea
Gestational Age
Vomiting
Disease Progression
Early Diagnosis
Blood Platelets
Morbidity
Pain
Liver

ASJC Scopus subject areas

  • Gastroenterology

Cite this

HELLP syndrome - Therapeutic dilemma. / Terzic, M. M.

In: Archives of Gastroenterohepatology, Vol. 17, No. 1, 01.01.1998, p. 32-36.

Research output: Contribution to journalReview article

@article{3a97f70e58a54a5f891e35fc0acf0cf7,
title = "HELLP syndrome - Therapeutic dilemma",
abstract = "HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) is a severe and life-threatening form of preeclampsia. The classical symptoms, despite the typical laboratory evaluation, are epigastric or right upper quadrant pain, nausea and vomiting; the classical signs of preeclampsia may be absent in 20{\%} of women. As no reliable clinical and laboratory indicators exist, as well as no precisely defined cut-off values in predicting the course and prognosis, the outcome of HELLP syndrome is unpredictable. The high maternal morbidity and mortality are mainly due to the development of disseminated intravascular coagulation (DIC); the frequency of DIC has been shown to increase significantly with the time interval between diagnosis and delivery. The management of HELLP syndrome has been controversial, with some authors recommending a conservative approach to induce fetal maturity in pregnancies below the 32(nd) (34(th)) week of gestation, whereas the majority recommend immediate delivery by Cesarean section in patients with an unfavorable cervix irrespective of the gestational age. It is generally agreed that early diagnosis by laboratory screening methods is mandatory and that patients with the HELLP syndrome should be transferred to a perinatal center. A literature review since 1990 clearly demonstrates that aggressive management is associated with a significant reduction in maternal and perinatal mortality. Conservative management is only justified in cases of fetal immaturity under of following conditions: a) no evidence of progression of the disease, b) no suspected or manifest DIC, c) fetal well-being, and d) intensive monitoring of the patient in cooperation with experienced anesthesiologists and neonatologists.",
author = "Terzic, {M. M.}",
year = "1998",
month = "1",
day = "1",
language = "English",
volume = "17",
pages = "32--36",
journal = "Archives of Gastroenterohepatology",
issn = "0354-2440",
publisher = "Serbian Medical Association",
number = "1",

}

TY - JOUR

T1 - HELLP syndrome - Therapeutic dilemma

AU - Terzic, M. M.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) is a severe and life-threatening form of preeclampsia. The classical symptoms, despite the typical laboratory evaluation, are epigastric or right upper quadrant pain, nausea and vomiting; the classical signs of preeclampsia may be absent in 20% of women. As no reliable clinical and laboratory indicators exist, as well as no precisely defined cut-off values in predicting the course and prognosis, the outcome of HELLP syndrome is unpredictable. The high maternal morbidity and mortality are mainly due to the development of disseminated intravascular coagulation (DIC); the frequency of DIC has been shown to increase significantly with the time interval between diagnosis and delivery. The management of HELLP syndrome has been controversial, with some authors recommending a conservative approach to induce fetal maturity in pregnancies below the 32(nd) (34(th)) week of gestation, whereas the majority recommend immediate delivery by Cesarean section in patients with an unfavorable cervix irrespective of the gestational age. It is generally agreed that early diagnosis by laboratory screening methods is mandatory and that patients with the HELLP syndrome should be transferred to a perinatal center. A literature review since 1990 clearly demonstrates that aggressive management is associated with a significant reduction in maternal and perinatal mortality. Conservative management is only justified in cases of fetal immaturity under of following conditions: a) no evidence of progression of the disease, b) no suspected or manifest DIC, c) fetal well-being, and d) intensive monitoring of the patient in cooperation with experienced anesthesiologists and neonatologists.

AB - HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) is a severe and life-threatening form of preeclampsia. The classical symptoms, despite the typical laboratory evaluation, are epigastric or right upper quadrant pain, nausea and vomiting; the classical signs of preeclampsia may be absent in 20% of women. As no reliable clinical and laboratory indicators exist, as well as no precisely defined cut-off values in predicting the course and prognosis, the outcome of HELLP syndrome is unpredictable. The high maternal morbidity and mortality are mainly due to the development of disseminated intravascular coagulation (DIC); the frequency of DIC has been shown to increase significantly with the time interval between diagnosis and delivery. The management of HELLP syndrome has been controversial, with some authors recommending a conservative approach to induce fetal maturity in pregnancies below the 32(nd) (34(th)) week of gestation, whereas the majority recommend immediate delivery by Cesarean section in patients with an unfavorable cervix irrespective of the gestational age. It is generally agreed that early diagnosis by laboratory screening methods is mandatory and that patients with the HELLP syndrome should be transferred to a perinatal center. A literature review since 1990 clearly demonstrates that aggressive management is associated with a significant reduction in maternal and perinatal mortality. Conservative management is only justified in cases of fetal immaturity under of following conditions: a) no evidence of progression of the disease, b) no suspected or manifest DIC, c) fetal well-being, and d) intensive monitoring of the patient in cooperation with experienced anesthesiologists and neonatologists.

UR - http://www.scopus.com/inward/record.url?scp=0031890273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031890273&partnerID=8YFLogxK

M3 - Review article

VL - 17

SP - 32

EP - 36

JO - Archives of Gastroenterohepatology

JF - Archives of Gastroenterohepatology

SN - 0354-2440

IS - 1

ER -